03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Estaporin : | |
Type | Medicine Authorised |
Originator | Restasis |
Agent | Droguerie R. Pharaon et Fils |
Distributor | Droguerie R. Pharaon et Fils |
Laboratory | Pharmaline Laboratories |
Manufacturer | Pharmaline SAL* |
Origin | Lebanon |
ATC | S01XA |
Estaporin :
Estaporin :
Estaporin :
Estaporin :
Estaporin :
Hazard Level |
---|
◼ Major |
◼ Moderate |
◼ Minor |
◼ Safe |
Estaporin :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Blepharitis | Uncommon |
Chalazion | Uncommon |
Conjunctival hyperaemia (Conjunctival redness) (Conjunctival injection) | Common |
Conjunctival irritation | Uncommon |
Conjunctival oedema | Uncommon |
Conjunctivitis | Uncommon |
Corneal decompensation | Uncommon |
Corneal infiltrates | Uncommon |
Corneal scar | Uncommon |
Deposit eye | Uncommon |
Eye discharge | Uncommon |
Eye irritation | Common |
Eye pain | Common |
Eye pruritus | Uncommon |
Eyelid erythema | Common |
Eyelid oedema | Common |
Eyelid pruritus | Uncommon |
Foreign body sensation in eyes | Uncommon |
Instillation site discomfort | Uncommon |
Instillation site erythema | Common |
Instillation site foreign body sensation | Uncommon |
Instillation site irritation | Common |
Instillation site lacrimation | Common |
Instillation site pain | Very Common |
Instillation site pruritus | Uncommon |
Instillation site reaction | Uncommon |
Iridocyclitis | Uncommon |
Keratitis | Uncommon |
Keratitis bacterial | Uncommon |
Lacrimal disorder | Uncommon |
Lacrimation increased (Epiphora) | Common |
Leukocyte count decreased (White blood cell count decreased) | Uncommon |
Ocular hyperaemia | Common |
Ophthalmic herpes zoster | Uncommon |
Vision blurred | Common |
Estaporin :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
Different Units By MoH Code
Estaporin MoH 11659 :
Form | Eye drops, emulsion |
Packaging | Bottle |
Package Size | 5ml |
Strength | 0.05% |
Public Price | 2815797.98 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 98723/1 |
Submission date | 2023 |
Registration Year | 13/06/2024 |
Price Comparison
● Country: | Lebanon | |
● Form: | Eye drops, emulsion | |
● Package Size: | 5ml | |
● Public Price: | 2815797.98 LBP | ( 2,815,797.98 LBP ) |
● Pack size unit used: | 200 | |
● Cost/Unit: | 14078,99 LBP | ( 14,078.00 LBP ) |
● Pricing Date: | 13/06/2024 |
You have to register to view this info
Drop File